Robert Boissoneault Oncology Inverness, FL - 34452

Robert Boissoneault Oncology is categorized under Oncologists in Inverness, FL and active since 1993.

Robert Boissoneault Oncology was established in 1993, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Lynn Eckhardt, Office Manager at the company’s single location by writing to 605 West Highland Boulevard, Inverness, Florida FL 34452 or by phoning (352) 726-3400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Robert Boissoneault Oncology
Contact Person: Lynn Eckhardt, Office Manager
Address: 605 West Highland Boulevard, Inverness, Florida 34452
Phone Number: (352) 726-3400
Website Address: rboi.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 1993
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Oncologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Robert Boissoneault Oncology was started in 1993 to provide professional Oncologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Lynn Eckhardt, Office Manager for inquiries that concern Robert Boissoneault Oncology by calling the company number (352) 726-3400, as your correspondence is most welcome. Additionally, the physical location of the single location of Robert Boissoneault Oncology can be found at the coordinates 28.8321,-82.33728 as well as the street address 605 West Highland Boulevard in Inverness, Florida 34452.

For its online presence, you may visit Robert Boissoneault Oncology’s website at rboi.com and engage with its social media outlets through on Twitter and on Facebook.